Statins × cardiovascular events

TrialThe New England journal of medicine2023

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.

Steven K Grinspoon et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 7,769 people · 2023

Randomised comparison

Reduced cardiovascular events

−35%−52% to −10%

Bigger than 8 in 10 for cardiovascular events

As reported

HR 0.65, 95% CI 0.48–0.90

One number in the abstract

the abstract, start to end

in the placebo group (hazard ratio, 0.65; 95% confidence interval [CI],

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 0.650.48–0.90
StatinsCardiovascular events

Statins × cardiovascular eventshelps?replicated

unlikelylikely
0.860.85 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

245 papers cite itlatest 60 shown

2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37486775